Pdf !link! | Clsi Document M45

Frequently used for fastidious organisms like Corynebacterium or the HACEK group to support growth without interfering with antimicrobial activity.

Includes guidelines for fastidious bacteria such as HACEK group organisms, Campylobacter spp., Pasteurella spp., Corynebacterium spp., Lactobacillus spp., and many others that are not addressed in standard documents.

Run designated QC strains simultaneously with patient isolates to ensure the testing system performs within specified limits. Conclusion

This group includes Aggregatibacter , Cardiobacterium , Eikenella , and Kingella species. They are fastidious Gram-negative bacilli known for causing subacute endocarditis. 6. Leuconostoc, Pediococcus, and Lactobacillus

Utilize the specific QC strains designated in M45 to validate your customized media and testing environments before reporting patient results. clsi document m45 pdf

The guideline details standardized methods to ensure consistent results: Broth Microdilution:

This includes organisms like Bacillus cereus , which can cause severe food poisoning and serious systemic infections in immunocompromised patients. 3. Campylobacter jejuni and Campylobacter coli

Defining the right broth or agar base to support growth. Incubation Conditions: Specifying temperature, atmosphere ( CO2cap C cap O sub 2 vs. anaerobic), and time.

The guideline includes specific interpretive criteria and testing conditions for a wide range of diverse genera, including: As medical interventions advance (e.g.

The current effective edition is (formerly known as M45-A3 and M45-A2). This document provides standardized methods for:

Zoonotic pathogen causing localized skin lesions or systemic disease.

These organisms are often associated with unique infection sites or patients with specific predispositions (e.g., immunocompromised individuals). Importance of Using CLSI M45 for Labs

Before M45, many of these organisms lacked standardized testing methods, making it difficult for labs to accurately determine effective treatments. The document provides a , detailing both broth microdilution and agar disk diffusion methods. It includes careful instructions on test performance, including media selection, incubation conditions, and quality control, ensuring that results are reliable and reproducible across different laboratories. and invasive devices)

CLSI document M45 provides essential, standardized methods for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria, filling a critical gap in laboratory practice. It establishes guidelines for testing organisms like Aeromonas , Bacillus , and Vibrio spp. to aid clinical decision-making when dealing with unique or rare infections. For more details, visit CLSI .

The CLSI M45 document is available for purchase on the CLSI website ( www.clsi.org ). The document can be downloaded as a PDF file.

As medical interventions advance (e.g., immunosuppressive therapies, organ transplants, and invasive devices), organisms previously considered non-pathogenic or environmental contaminants are increasingly recognized as opportunistic pathogens. Key Organisms Covered in CLSI M45

Without M45, laboratories would be left guessing on drug selection and interpretation for critical, albeit rarer, infections. Key Organisms Covered

Meets clinical laboratory standards (e.g., CLIA, CAP) for testing methods.